SCM
MXCT icon

Sterling Capital Management’s MaxCyte MXCT Stock Holding History

Sterling Capital Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.35K Sell
3,347
-2,481
-43% -$2.32K ﹤0.01% 2959
2025
Q4 		$9.03K Sell
5,828
-1,149
-16% -$1.83K ﹤0.01% 2661
2025
Q3 		$11K Buy
6,977
+4,141
+146% +$7.2K ﹤0.01% 2442
2025
Q2 		$6.18K Buy
2,836
+1,010
+55% +$2.45K ﹤0.01% 2403
2025
Q1 		$4.99K Sell
1,826
-1,526
-46% -$6.02K ﹤0.01% 2166
2024
Q4 		$13.9K Buy
3,352
+2,985
+813% +$11.3K ﹤0.01% 2003
2024
Q3 		$1.43K Buy
+367
New +$1.55K ﹤0.01% 2361

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Sterling Capital Management's MXCT Position: Q1 2026 in Review

Sterling Capital Management reduced its MaxCyte (MXCT) stake by 43% in Q1 2026, selling an estimated $2.32K and leaving 3,347 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #2959.

Sterling Capital Management first reported a position in MXCT in Q3 2024 and has held it in 7 quarters since. The position peaked at $13.9K in Q4 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Sterling Capital Management held 3,347 shares of MaxCyte worth $2.35K as of Q1 2026.
  • Sterling Capital Management sold 2,481 MaxCyte shares in Q1 2026, an estimated $2.32K.
  • MaxCyte made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2959 holding.
  • Sterling Capital Management first reported a position in MaxCyte in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's MaxCyte position peaked at $13.9K in Q4 2024.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.